Carlos Martin (Carlos Martín)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 15

Top Venues

Nature communications

PLoS pathogens

Human vaccines & immunotherapeutics

mBio

University of Zaragoza

University of Paris VII (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Zaragoza

Spain

Microbiology Professor

Education History

University of Paris VII

France

PHD :: Institut Pasteur

Publications

Eduardo Moreo, Aitor Jarit-Cabanillas, Iñaki Robles-Vera, Santiago Uranga, Claudia Guerrero, Ana Belén Gómez, Pablo Mata-Martínez, Luna Minute, Miguel Araujo-Voces, María José Felgueres, Gloria Esteso, Iratxe Uranga-Murillo, Maykel Arias, Julian Pardo, Carlos Martin, Mar Valés-Gómez, Carlos Del Fresno Sánchez, David Sancho, Nacho Aguiló
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung. Nature communications 14 (1) (2023)
Eduardo Moreo, Santiago Uranga, Ana Picó, Ana Belén Gómez, Denise Nardelli-Haefliger, Carlos Del Fresno Sánchez, Ingrid Murillo, Eugenia Puentes, Esteban Rodríguez, Mar Vales-Gómez, Julian Pardo, David Sancho, Carlos Martin, Nacho Aguiló
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors. Journal for immunotherapy of cancer 10 (7) (2022)
Federico M Torres, Adolfo García-Sastre, Andrew J Pollard, Carlos Martin, Albert Osterhaus, Shamez N Ladhani, Octavio Ramilo, Jose Gómez Rial, Antonio Salas, F Xavier Bosch, María Martinón-Torres, Michael J Mina, James Cherry
TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO). Human vaccines & immunotherapeutics (2021)
Andrew D White, Laura Sibley, Charlotte Sarfas, Alexandra Morrison, Jennie Gullick, Simon Clark, Fergus Gleeson, Anthony McIntyre, Cecilia S Lindestam Arlehamn, Alessandro Sette, Francisco Javier Salguero, Emma Rayner, Esteban Rodriguez, Eugenia Puentes, Dominick Laddy, Ann Williams, Mike Dennis, Carlos Martin, Sally Sharpe
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies. NPJ vaccines 6 (1) (2021)
Elena Mata, Raquel Tarancon, Claudia Guerrero, Eduardo Moreo, Flavie Moreau, Santiago Uranga, Ana Belen Gomez, Dessislava Marinova, Miriam Domenech, Fernando González Camacho, Marta Monzon, Juan Badiola, Mihai G Netea, Jose Yuste, Alberto Anel, Antonio Peixoto, Carlos Martin, Nacho Aguiló
Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis. Science immunology 6 (63) (2021)
Elena Mata, Damien Farrell, Ruoyao Ma, Santiago Uranga, Ana Belen Gomez, Marta Monzon, Juan Badiola, Alberto Anel, Jesús Gonzalo-Asensio, Carlos Martin, Stephen Vincent Gordon, Nacho Aguiló
Independent genomic polymorphisms in the PknH serine threonine kinase locus during evolution of the Mycobacterium tuberculosis Complex affect virulence and host preference. PLoS pathogens 16 (12) (2020)
Raquel Tarancon, Mihai G Netea, Santiago Uranga, Anaísa V Ferreira, Laszlo A Groh, Miriam Domenech, Fernando González-Camacho, Niels P Riksen, Nacho Aguilo, José Yuste, Carlos Martin, Mihai G Netea
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia. PLoS pathogens 16 (4) (2020)
Raquel Tarancón, Santiago Uranga, Carlos Martin, Nacho Aguiló
Mycobacterium tuberculosis infection prevents asthma and abrogates eosinophilopoiesis in an experimental model. Allergy 74 (12) (2019)
Federico M Torres, Xavier Bosch, Rino Rappuoli, Shamez Ladhani, Esther Redondo, Timo Vesikari, Adolfo García-Sastre, Irene Rivero-Calle, José Gómez-Rial, Antonio Salas, Carlos Martin, Adam Finn, Robb Butler
TIPICO IX: report of the 9th interactive infectious disease workshop on infectious diseases and vaccines. Human vaccines & immunotherapeutics 15 (10) (2019)
Mario Tovar, Sergio Arregui, Dessislava Marinova, Carlos Martin, Joaquín Sanz, Yamir Moreno
Bridging the gap between efficacy trials and model-based impact evaluation for new tuberculosis vaccines. Nature communications 10 (1) (2019)
Laura Pérez-Lago, María Isolina Campos-Herrero, Fernando Cañas, Rodolfo Copado, Laura Sante, Berta Pino, María Lecuona, Óscar Díez Gil, Carlos Martin, Patricia Muñoz, Darío García-de-Viedma, Sofía Samper
A Mycobacterium tuberculosis Beijing strain persists at high rates and extends its geographic boundaries 20 years after importation. Scientific reports 9 (1) (2019)
Sergio Arregui, María José Iglesias, Sofía Samper, Dessislava Marinova, Carlos Martin, Joaquín Sanz, Yamir Moreno
Data-driven model for the assessment of Mycobacterium tuberculosis transmission in evolving demographic structures. Proceedings of the National Academy of Sciences of the United States of America 115 (14) (2018)
Jesus Gonzalo-Asensio, Irene Pérez, Nacho Aguiló, Santiago Uranga, Ana Picó, Carlos Lampreave, Alberto Cebollada, Isabel Otal, Sofía Samper, Carlos Martin
New insights into the transposition mechanisms of IS6110 and its dynamic distribution between Mycobacterium tuberculosis Complex lineages. PLoS genetics 14 (4) (2018)
Nacho Aguilo, Jesus Gonzalo-Asensio, Samuel Alvarez-Arguedas, Dessislava Marinova, Ana Belen Gomez, Santiago Uranga, Ralf Spallek, Mahavir Singh, Regine Audran, François Spertini, Carlos Martin
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis. Nature communications 8 (2017)
Esther Broset, Carlos Martin, Jesus Gonzalo-Asensio
Evolutionary landscape of the Mycobacterium tuberculosis complex from the viewpoint of PhoPR: implications for virulence regulation and application to vaccine development. mBio 6 (5) (2015)

Carlos Martin.css-eqlu8i{font-size:small;padding-left:4px;} (Carlos Martín)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlos Martin (Carlos Martín)